Jean J. Zhao
Molecular Biology · 2007–2017
A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 118 citations into it
- Cell Biology — 12 citations into it
Whom Jean J. Zhao trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- J. Backer (in Molecular Biology)
Papers from Jean J. Zhao's perspective
Ordered by how strongly the researchers Jean J. Zhao trusts endorse each paper. Same corpus, a different order for every researcher.
- TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling (Nature Cell Biology)
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancer (Nature Reviews. Cancer)
- Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
- Upstream and downstream of mTOR. (Genes & Development)
- TOR signaling in growth and metabolism. (Cell)
- A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
- Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. (Genes & Development)
- Targeting RAS signalling pathways in cancer therapy (Nature Reviews. Cancer)
- Cellular function of phosphoinositide 3-kinases: Implications for development, immunity, homeostasis, and cancer
- A large-scale RNAi screen in human cells identifies new components of the p53 pathway (Nature)
Their papers
- Targeting the phosphoinositide 3-kinase (PI3K) pathway in cancer (2009) — 2,573 citations
- PI3K in cancer: divergent roles of isoforms, modes of activation, and therapeutic targeting (2014) — 1,246 citations
- Integrative genomic approaches identify IKBKE as a breast cancer oncogene. (2007) — 645 citations
- COT/MAP3K8 drives resistance to RAF inhibition through MAP kinase pathway reactivation (2010) — 731 citations
- CDK4/6 inhibition triggers anti-tumor immunity (2017) — 1,277 citations